Metis TechBio
$18.70Change from previous close: +0.97%Absolute change: +$0.18
Valuation
Data as of October 4, 2026
Valuation multiples
- Market cap
- $21.9B
- Enterprise value
- $19.21B
- Forward P/E
- -461.0
- Price/book
- 6.20
- Price/sales
- 84.8
- EV/EBITDA
- -62.5
- EV/revenue
- 74.4
Profitability and growth
- Gross margin
- 98.9%
- Operating margin
- -86.8%
- Net margin
- -137.0%
- Revenue growth (year over year)
- 13,398.9%
Financial health
- Total cash
- $2.87B
- Total debt
- $179.28M
- Debt/equity
- 0.06
- Current ratio
- 17.7
- Quick ratio
- 17.6
Dividends
- Payout ratio
- 0.0%
Analysts and estimates
- Average price target
- $24.63
- Median price target
- $24.63
- High price target
- $30.06
- Low price target
- $19.21
- Analysts with a price target
- 2
- Forward EPS
- -$0.04
- EPS estimate, current year
- -$0.09
Shares and trading
- Average volume
- 5.6M
- Shares outstanding
- 1.08B
- Float
- 553.8M
- Institutional ownership
- 23.1%
- Insider ownership
- 66.0%